Exclusive Summary

• Fully US-FDA GMP certified with an approved US ANDA, demonstrating top-tier quality that facilitates rapid regulatory approval via reliance pathways in other markets.
• Functions as a non-stimulant ADHD medication with no addiction potential, bypassing the strict import, export, and distribution regulations typical for controlled substances.
• Addresses a massive global market with a 5%-7% prevalence of ADHD in youths (over 80 million patients), offering a full range of dosages (1-4mg) to meet standard clinical titration needs.
• Leverages China's cost-effective and highly reliable manufacturing to provide significant price advantages, empowering global distributors to win government tenders and outcompete originators.